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ABSTRACT 
 
 
Beiraghi Salek, Asma. M.S., Purdue University, August 2016. Mechanisms and 
Consequences of Regulating the Spinophilin/NMDA Receptor Interaction. Major 
Professor: A.J. Baucum. 
 
Parkinson disease (PD) is the second most common neurodegenerative disease. It is 
characterized by loss of dopaminergic cells in the substantia nigra, which causes loss of 
dopaminergic synapses onto striatal medium spiny neurons (MSNs). Dendritic spines that 
are localized to these striatal MSNs receive synaptic inputs from both the nigral dopamine 
neurons and cortical glutamate neurons. Signaling downstream of excitatory, glutamatergic 
drive is modulated by dopamine. This tripartite connection: glutamate, dopamine, and 
MSN dendritic spine, is important for normal motor function. Glutamate released from 
presynaptic terminals binds to and activates two classes of inotropic glutamate receptors 
that are localized to dendritic spines on striatal MSNs: the α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid receptor (AMPAR) and the N-methyl-D-aspartate receptor 
(NMDAR). Once these receptors are activated, they allow for Ca2+ influx, which in turn 
activates Ca2+-dependent processes that underlie neural plasticity, including long-term 
potentiation (LTP) and long-term depression (LTD). Proper machinery in the pre- and post-
synaptic neurons is required for normal signal transduction. Moreover, this signal 
transduction requires proper organization of synaptic proteins, which is achieved by
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specific protein-protein interactions. These protein-protein interactions are dynamic and 
can be modulated under various conditions, including pathological changes in the
phosphorylation status of a specific protein. Catalytically active proteins called 
phosphatases and kinases specifically regulate the phosphorylation status of synaptic 
proteins. Pathologically, in PD there is increased autophosphorylation and activation of 
Ca2+/calmodulin-dependent protein kinase II (CaMKII). This increased phosphorylation 
may be due to changes in the activity of the serine/threonine protein phosphatase 1 (PP1), 
a highly conserved protein serine/threonine phosphatase that has a diverse set of functions 
in eukaryotes. Serine/threonine phosphatase substrate specificity is obtained via 
interactions with targeting and regulatory proteins. One such protein, spinophilin, is a 
scaffolding protein that targets PP1 to various synaptic substrates to regulate their 
phosphorylation. Interestingly, the association of PP1 with spinophilin is enhanced in a rat 
model of PD. The NMDAR is another protein that has altered phosphorylation in animal 
models of PD. We have found that there is a decrease in the NMDAR-spinophilin 
interaction in an animal model of PD. Here, we have found that spinophilin and the 
NMDAR interact in brain tissue and when overexpressed in a mammalian cell system. 
Moreover, we have identified novel mechanisms that regulate this interaction and have 
identified putative consequences of altering this association. These studies give us novel 
insight into mechanisms and consequences underlying pathological changes observed in 
an animal model of PD. Understanding these changes will inform novel therapeutic targets 
that may be useful in modulating striatal function.   
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1 INTRODUCTION 
 
 
 Parkinson Disease History and Pathology 
Parkinson disease (PD) is a neurodegenerative disease that was first described about 
two centuries ago by James Parkinson. He described this disease with four main hallmarks 
including resting tremor, postural and gait instability, and hypokinesia (Parkinson, 2002). 
Friedrich Lewy was the first person who started to study this disease from a histological 
standpoint in the early 20th century and successfully characterized the major 
histopathological markers of the disease (Lewy, 1913) which were named Lewy Bodies 
later. Lewy bodies contain α-synuclein aggregates that interfere with normal cell function, 
resulting in the death of presynaptic cells (Spillantini et al., 1997).  
The substantia nigra is a brain region that is most affected in PD, leading to a severe 
atrophy and a loss of pigment therein. Loss of approximately 80% of the dopaminergic 
neurons in the substantia nigra will lead to appearance of motor deficits (Rodriguez-Oroz 
et al., 2009). There are various forms of PD, but the sporadic form is the most common. 
Currently, the exact mechanisms linked to the sporadic form are not fully understood. 
However, environmental factors, gene-environment interactions, and gene-gene 
interactions may play a role.  
 Other forms of PD have familial or genetic roots. The most common known 
mutations leading to familial PD are observed in the LRRK2 (leucine-rich repeat kinase 2) 
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and SNCA (synuclein) genes among others (Lesage et al., 2006; Polymeropoulos et al., 
1997). These and other proteins are known to regulate mitochondrial function, protein 
aggregation, and/or protein degradation. This protein aggregation may underlie some of 
the PD pathology, such as Lewy body formation. Formation of Lewy bodies can then result 
in perturbations in synaptic communication and cell death (Gibb & Lees, 1988; Spillantini 
et al., 1997). 
 L-DOPA is the most commonly prescribed drug for treating PD. L-DOPA is a 
precursor of dopamine, and is used to replace the loss of dopamine released by nigral 
dopaminergic neurons (Dauer & Przedborski, 2003). In PD patients, L-DOPA is converted 
to DA in the remaining dopaminergic neurons and this acts to attenuate many of the motor 
symptoms associated with PD (Hornykiewicz, 1974). Despite L-DOPA’s positive effects, 
long-term treatment with L-DOPA will lead to the appearance of side effects including an 
increase in involuntary movements known as dyskinesias (Cenci, Lee, & Bjorklund, 1998; 
Pearce, Jackson, Smith, Jenner, & Marsden, 1995). Moreover, the efficacy of L-DOPA 
also wanes over time, in part due to a further loss of dopamine neurons and changes in 
functional synaptic connectivity in the striatum. Deep-brain stimulation (DBS) of the 
subthalamic nucleus or the globus pallidus is a more recent treatment for PD. In this method 
of treatment, electrodes are implanted directly into the brain regions mentioned above, and 
pulses are generated at a specific frequency. This method has proven to be successful in 
attenuating the severity of PD motor symptoms (Kumar et al., 1998); Deep-Brain 
Stimulation for Parkinson's Disease Study Group 2001). While both of these treatments are 
proven to help PD patients, they only treat the symptoms of PD. Unfortunately there is no 
proven treatment for healing the underlying causes of the disease which has proven to be 
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much more difficult (Shulman, De Jager, & Feany, 2011). This is due, in part, to a lack of 
understanding of the changes in functional connectivity that occur in the striatum following 
loss of dopamine neurons. 
 Brain Function and Parkinson Disease 
Proper synaptic connectivity is essential for normal brain function. One example of 
a neural circuit and connectivity in the brain is dopaminergic projections from the 
substantia nigra and glutamatergic projections from motor cortex that both synapse on 
small protrusions called dendritic spines that are localized to striatal medium spiny neurons 
(MSNs). Once the synapse is formed, proper machinery in the pre- and post-synaptic 
neurons is needed for normal signal transduction, which underlies appropriate synaptic 
connectivity. This machinery that is essential for signal transduction is a protein dense 
specialization in the tip of the spines referred as to the postsynaptic density (PSD) (Hausser, 
Spruston, & Stuart, 2000). MSN dendritic spines were first described by Ramón y Cajal 
(Cajal, 1888). These small protrusions play a significant role in proper synaptic 
connectivity since they serve as the main site to receive presynaptic input by significantly 
increasing the overall dendrite surface area (Gray, 1959).  
Upon glutamate release from the pre-synaptic neuron, glutamate will bind to its 
receptors that reside on the dendritic spines of MSNs. α-Amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPAR) and N-methyl-D-aspartate receptor (NMDAR) 
are two inotropic glutamate receptors that are localized to dendritic spines on striatal 
MSNs. Following glutamate activation of postsynaptic receptors, Ca2+ fluxes into the cell, 
which in turn activates Ca2+-dependent processes. This glutamate signal is modulated by 
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the release of dopamine (DA). Specifically, two classes of DA receptors reside on two 
unique populations of striatal MSNs: the DA D1R-containing, or direct pathway MSNs, 
and the DA D2R-containing, or indirect pathway MSNs (Strange, 1993). The D1 family of 
receptors that activate the direct pathway are Gαs-protein-coupled and upon ligand binding 
activate adenylyl cyclase which in turn will activate protein kinase A (PKA) signaling. 
Conversely, the D2-family of DA receptors are found on indirect pathway striatal MSNs, 
are Gαi-coupled, and inhibit adenylyl cyclase, which blocks downstream PKA signaling 
(Stoof & Kebabian, 1984). The balance between direct and indirect pathways is essential 
for normal motor control, with the direct pathway being linked to initiation of normal 
movement and the indirect pathway suppressing unintentional or inappropriate movements 
(Albin, Young, & Penney, 1989; Frank, Seeberger, & O'Reilly R, 2004). 
 As mentioned previously, loss of nigral dopaminergic projections causes alterations 
in the functionality of striatal MSNs (German, Manaye, Smith, Woodward, & Saper, 1989), 
such as modulation of normal PKA signaling (Nishi et al., 2008), as well as the appearance 
of motor deficits associated with PD (Albin et al., 1989; Rodriguez-Oroz et al., 2009; Starr, 
1995). Molecularly, DA depletion alters the functionality of PSD proteins. Previous studies 
have shown that PSD proteins are critical for normal synaptic communication. Specifically, 
knocking out one or more of these synaptic proteins leads to changes in normal synaptic 
function and connectivity. One of the proteins that has altered functionality following DA 
depletion is the NMDAR. NMDARs are glutamate receptors that underlie long-term 
potentiation (LTP) and/or long-term depression (LTD), molecular correlates of learning 
and memory (Malenka & Bear, 2004). Moreover, DA depletion affects LTP and LTD in 
both PD patients and animal models of PD. Specifically, 6-hydroxydopamine (6-OHDA)-
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lesion of the substantia nigra in rats leads to loss of LTD (Calabresi, Maj, Pisani, Mercuri, 
& Bernardi, 1992; Ingham, Hood, Taggart, & Arbuthnott, 1998). However, the specific 
changes that occur in NMDAR function that link to these pathological changes in learning 
and memory observed in animal models of PD are unclear. 
 NMDAR Function and Localization 
Glutamatergic synapses regulate most of the excitatory neurotransmission in the 
mammalian brain and play a critical role in mediating functional neuronal connectivity. 
Glutamate released from presynaptic axons activates several glutamate-gated ion channels 
on postsynaptic cells including AMPARs, NMDARs, and kainate receptors, which get their 
names from their specific response to pharmacological agents (Dingledine, Borges, Bowie, 
& Traynelis, 1999; Hollmann & Heinemann, 1994). It has been shown that dysfunction of 
these receptors is associated with multiple neurological and psychiatric disorders, 
including Parkinson disease, Alzheimer disease, and schizophrenia (S. Cull-Candy, 
Brickley, & Farrant, 2001; Waxman & Lynch, 2005). 
As mentioned above, NMDARs are a major class of glutamate receptors. These 
receptors have several subunits and three families of genes (Grin1, Grin2 and Grin3) that 
encode three families of proteins (GluN1, GluN2, and GluN3) (S. Cull-Candy et al., 2001). 
Studies show that NMDARs are tetramers in which two GluN1 subunits assemble with two 
NR2 and/or one NR2 and one NR3 subunit. GluN1 subunits are obligatory subunits 
necessary for functional expression of the NMDA receptors (S. G. Cull-Candy & 
Leszkiewicz, 2004). According to biochemical, electrophysiological and crystallographic 
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analysis, a GluN1/ GluN2 heterodimer is the functional unit in tetrameric NMDARs 
(Furukawa, Singh, Mancusso, & Gouaux, 2005). 
 The NMDAR is a voltage-sensitive glutamate receptor, which is blocked by 
extracellular Mg2+ ion under resting membrane potential. The blocking Mg2+ ion acts as a 
switch that allows for Ca2+ influx upon membrane depolarization together with binding of 
glutamate to the GluN2 subunit and a co-agonist, such as glycine, to the GluN1 subunit 
(Erreger, Chen, Wyllie, & Traynelis, 2004).  
 Many studies have shown that GluN2 and GluN3 subunits connote specific 
electrophysiological properties to the NMDARs (S. G. Cull-Candy & Leszkiewicz, 2004). 
As a result, variability in NMDAR subunit composition is an important factor to regulate 
NMDAR function. According to previous studies, subunit composition of NMDARs is 
developmentally regulated (Monyer, Burnashev, Laurie, Sakmann, & Seeburg, 1994). The 
GluN1 subunit is the product of a single gene, which can be alternatively spliced, and 
normally is found ubiquitously throughout the brain. In contrast, GluN2 subunits 
(GluN2A-D) are encoded by four different genes and their expression patterns depend on 
the developmental stage and brain region. The expression patterns of GluN2A and GluN2B 
throughout the brain are relatively broad, with a parallel decrease in GluN2B and increase 
in GluN2A expression. However GluN2C and GluN2D have a more restricted expression, 
with GluN2C expression in cerebellum starting later in development and GluN2D being 
expressed early in development mostly in the brainstem and in thalamic and hypothalamic 
nuclei (Monyer et al., 1994). Endogenous NMDARs normally only contain GluN1 and 
GluN2 subunits, with GluN3 subunits only incorporated in a subpopulation of NMDARs 
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and exhibiting decreased channel conductance properties (S. G. Cull-Candy & 
Leszkiewicz, 2004). 
From a structural standpoint, NMDAR subunits contain several domains including a 
long extracellular N-terminal domain, a membrane-spanning domain, a pore loop, and a 
subunit-dependent, variable length intracellular C-terminal domain. The C-terminal “Tail” 
domain is the most variable region when comparing the various NMDAR subunit 
sequences. The Tail region is known to regulate receptor interactions with various 
intracellular proteins. These protein-protein interactions are important for proper 
trafficking and localization of NMDARs to membranes. Additionally, different subunits of 
the NMDAR can couple receptors to various cytosolic signaling complexes. For instance, 
GluN2B interacts with various proteins such as SynGAP (Kim, Dunah, Wang, & Sheng, 
2005) and an active form of CaMKII (Colbran et al., 1997), which leads to differing forms 
of synaptic plasticity (Barria & Malinow, 2005). Furthermore, the tail region of NMDARs 
is subject to various post-translational modifications such as phosphorylation, which can 
directly modulate protein activity, interactions, localization, and mobility. 
 Protein Kinases and Phosphatases 
Protein kinases and phosphatases regulate substrate protein phosphorylation. These 
proteins are some of the most widely expressed enzymes in eukaryotes. Some studies 
estimate that the human genome encodes about 500 kinases (Manning, Whyte, Martinez, 
Hunter, & Sudarsanam, 2002) and 150 phosphatases (P. T. Cohen, 2002). Moreover, it is 
known that these enzymes play very important roles in neuronal processes such as 
axon/dendrite formation and synaptic plasticity (Soderling, 2000). 
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Normally, protein phosphorylation is modulated by a balance between phosphatase 
and kinase activity. As a result, regulation of phosphatase or kinase activity and their 
localization can have significant effects on substrate phosphorylation (P. Cohen, 1992; 
Meiselbach, Sticht, & Enz, 2006). There are multiple classes of kinases and phosphatases. 
One specific class, the serine/threonine family of kinases and phosphotases, phosphorylates 
or dephosphorylates serine and/or threonine residues. Studies suggest that there are ~385 
known serine/threonine kinases (Manning et al., 2002), while there are only ~40 known 
serine/threonine phosphatases (P. T. Cohen, 2002). Given the discrepancy in the number 
of kinases and phosphatases, serine/threonine phosphatases associate with specific 
targeting or regulatory proteins to obtain substrate specificity (P. T. Cohen, 2002; Janssens, 
Longin, & Goris, 2008; J. D. Scott & Pawson, 2009). 
Protein kinase A (PKA) is a highly abundant serine/threonine kinase in the CNS and 
is known to play an integral role in modulating glutamate receptor phosphorylation 
(Tingley et al., 1997). Glutamate receptor phosphorylation underlies various neurological 
processes such as LTP and LTD (Raymond, Blackstone, & Huganir, 1993; Roche, Tingley, 
& Huganir, 1994). Moreover, PKA is important in cell development, where its activation 
increases neurite formation in developing cells (Vogt Weisenhorn, Roback, Kwon, & 
Wainer, 2001). Furthermore, PKA activity is altered in rat models of Parkinson disease and 
following long-term L-DOPA treatment (Oh, Del Dotto, & Chase, 1997). Linking PKA 
activity to PD, dopamine signaling modulates PKA activity. As stated above, D1 dopamine 
receptor activation increases adenylyl cyclase activity (Herve et al., 2001; Sibley & 
Monsma, 1992; Stoof & Kebabian, 1984). Active adenylyl cyclase cleaves off the 
phosphate group from ATP and folds the molecule to form cAMP. cAMP, which is a 
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critical second messenger, will then bind to the PKA regulatory subunit, allowing for the 
release of the PKA catalytic subunit (PKAc) which will in turn phosphorylate specific 
substrates. Conversely, activation of D2 dopamine receptors inhibits adenylyl cyclase, 
resulting in PKA inhibition (Sibley & Monsma, 1992; Stoof & Kebabian, 1984). As 
mentioned previously, dopaminergic neurons synapse on striatal MSNs, which also receive 
excitatory glutamatergic inputs from cortex. As a result, activation or inhibition of PKA 
activity affects glutamate receptor phosphorylation (Tingley et al., 1997). 
Cyclin-dependent kinase 5 (CDK5) is another important protein kinase that is 
believed to affect the cell cycle and play a role in cellular development. CDK5 is a 
misnomer, since it has been demonstrated that cyclins are not essential for its activity 
(Dhavan & Tsai, 2001). It is shown that removal of CDK5 expression in mice is fatal 
because of improper cortex formation. This effect was specific to central nervous system 
tissue since formation of other organs was unaffected (Ohshima et al., 1996). Moreover, 
studies suggest that CDK5 is known to regulate neurite growth in newly differentiated 
cells. CDK5 is also known to phosphorylate Tau, an important neuronal protein 
contributing to its aggregation in Alzheimer disease (Baumann, Mandelkow, Biernat, 
Piwnica-Worms, & Mandelkow, 1993).  
Interestingly, CDK5 plays an important role in dopamine-signaling pathways. 
DARPP-32 phosphorylation by CDK5 inhibits PKA activity (Bibb et al., 1999). Protein 
phosphatase inhibitor 1 is also known to be phosphorylated by CDK5, which keeps PP1 in 
an active state and implicates CDK5 as a PKA antagonist (Bibb et al., 2001).  
As stated before, phosphatases are diametrically opposed to kinases via their ability 
to dephosphorylate specific substrates. One of the well-known serine/threonine 
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phosphatases is PP1. This phosphatase is localized to dendritic spines in neurons and is an 
important regulator of synaptic function. PP1 catalytic subunits associate with >50 
regulatory or targeting proteins (P. T. Cohen, 2002), usually via an R-V-x-F motif on the 
targeting protein (Ceulemans & Bollen, 2006; Meiselbach et al., 2006). Spinophilin is the 
major PP1 binding protein in the PSD (Colbran et al., 1997) that acts to target PP1 to 
myriad synaptic substrates (Allen, Ouimet, & Greengard, 1997). Moreover, PP1 is known 
to play a role in the down-regulation of AMPA receptors (Yan et al., 1999). The former 
study also shows that PP1-spinophilin dissociation leads to AMPAR dephosphorylation, 
allowing for decreases in channel activity. Interestingly, more recent studies have also 
shown that spinophilin can target PP1 to protein kinases such as CaMKII and this targeting 
increases in an age-dependent manner (Baucum, Strack, & Colbran, 2012). Together, these 
data suggest that proper synaptic formation and function depends on various kinase and 
phosphatase activity and the balance between their function.  
 NMDA Receptor Phosphorylation 
Direct phosphorylation of ionotropic glutamate receptors plays a very integral role 
in regulating channel conductance, function, and receptor localization at synapses (Lee, 
2006). NMDA receptor subunits are phosphorylated at serine/threonine residues by 
multiple kinases, including PKA, protein kinase B (PKB), protein kinase C (PKC), CDK5, 
CaMKII, and casein kinase II (CKII) (Mammen, Kamboj, & Huganir, 1999; Roche et al., 
1994). In addition to kinases and phosphatases, per se, phosphorylation of synaptic proteins 
that modulate kinase or phosphatase targeting also regulate NMDAR phosphorylation (Lan 
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et al., 2001; Sigel, Baur, & Malherbe, 1994; Zheng, Zhang, Wang, Bennett, & Zukin, 
1999). 
 PKC has multiple effects on NMDAR function, including increasing the opening 
rate and upregulating NMDAR surface expression, which in turn regulates NMDAR 
activity (Lan et al., 2001; W. Y. Lu et al., 1999). PKA also plays a role in mediating 
NMDAR function by enhancing the amplitude of NMDAR-mediated excitatory 
postsynaptic currents (EPSCs) (Raman, Tong, & Jahr, 1996). Consistently, PKA activation 
seems to increase synaptic targeting of NMDA receptors (Crump, Dillman, & Craig, 2001) 
along with increasing calcium permeability of NMDARs (Skeberdis et al., 2006). 
 GluN1, the obligate subunit of the NMDAR, is also phosphorylated by various 
protein kinases (PK). Studies suggest that phosphorylation of serine 890 disrupts GluN1 
clustering (Tingley et al., 1997) while serine 896 phosphorylation by PKC has no effect on 
clustering of GluN1. However, phosphorylation of S896 together with PKA 
phosphorylation of S897 contributes to increase in NMDA receptor surface localization 
(D. B. Scott, Blanpied, Swanson, Zhang, & Ehlers, 2001). GluN2A can be phosphorylated 
by PKC, which leads to phosphorylation of S1291 and S1312 and potentiation of GluN2A-
containing NMDARs (Grant, Guttmann, Seifert, & Lynch, 2001; Jones & Leonard, 2005). 
Phosphorylation of GluN2A at S1416 by PKC decreases the GluN2A binding affinity to 
CaMKII (Gardoni et al., 2001). CDK5 is another PK that also phosphorylates GluN2A, 
which contributes to an increase in NMDA receptor activity (B. S. Li et al., 2001). 
  GluN2B constitutes most of the NMDARs in most brain regions early in 
development (S. Cull-Candy et al., 2001). While GluN2B expression is attenuated as the 
animal matures, it remains in hippocampus, cortex, striatum and other brain regions into 
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adulthood. GluN2B containing NMDARs are located at both synaptic and extrasynaptic 
sites early in development. As development progresses, GluN2B becomes enriched at 
extrasynaptic sites (B. Li et al., 2002; Tovar & Westbrook, 1999). Moreover, GluN2B-
containing NMDA receptors have higher surface mobility compared to GluN2A-
containing NMDARs (Groc et al., 2006). Like GluN2A, GluN2B-containing receptors are 
also phosphorylated by PKC. Specifically, PKC phosphorylates GluN2B at S1303 and 
S1323 (Liao, Wagner, Hsu, & Leonard, 2001). Intriguingly, other studies show that S1303 
of GluN2B is also a phosphorylation site for CaMKII (Omkumar, Kiely, Rosenstein, Min, 
& Kennedy, 1996). Phosphorylation of Serine 1303 by CaMKII modulates NMDAR 
function in a different way from phosphorylation of PKC of the same site. CKII is another 
PK that phosphorylates GluN2B on S1480, which is localized to the PDZ domain at the 
extreme C-terminus. Phosphorylation of this site disrupts the GluN2B/PSD95 interaction.  
PKA also plays a role in GluN2B phosphorylation on S1166 (Murphy et al., 2014), 
which is critical in synaptic NMDAR function and Ca2+ signaling in spines. Along with 
this PKA site, Y1472 (Zhang, Edelmann, Liu, Crandall, & Morabito, 2008), S1116 
(Plattner et al., 2014) and S1284 are recently characterized phosphorylation sites that are 
either indirectly or directly phosphorylated by CDK5 and can modulate NMDAR function 
(W. Lu et al., 2015). Together, these data suggest that phosphorylation of NMDA receptor 
subunits plays an integral role in proper signaling as well as normal synaptic connectivity. 
 Spinophilin Function and Localization 
As mentioned above, many molecules, proteins, and enzymes including phosphatases and 
kinases underlie normal synaptic signaling in the PSD. One of highly conserved molecules 
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that has  a wide range of activity in eukaryotes is PP1 (Mathieu Bollen, Peti, Ragusa, & 
Beullens, 2010). This ubiquitous protein phosphatase regulates a wide array of cellular 
processes through the association of its catalytic subunit with regulatory proteins (P. T. 
Cohen, 2002). The majority of these regulatory proteins are targeting or scaffolding 
proteins that can target PP1 to various substrates (P. T. Cohen, 2002). In 1997, a new 
protein was observed in PP1 immunoprecipitations of mouse brain lysates. This protein 
had a lot in common with another PP1 binding protein (Satoh et al., 1998) discovered 
before, referred to as “Neurabin” in their amino acid sequence and their PP1 binding ability 
(Egloff et al., 1997). The new PP1 binding protein known as Neurabin II got its new name, 
spinophilin, because of its abundance in neural spines (Allen et al., 1997). The spinophilin 
gene, PPP1R9B (gene ID 84687) is localized on chromosome 17, 17q21.33 and consists 
of 10 exons. Analysis of PP1 holoenzyme of rat brain shows that neurabin and spinophilin 
both associate with different isoforms of PP1 (MacMillan et al., 1999). Other studies show 
that this protein is not only enriched in synapses but also in cadherin cell-cell adhesion sites 
(Satoh et al., 1998).  
 This well characterized PP1 targeting protein has 817 amino acids and consists of 
multiple domains that mediate protein-protein interactions: including an N-terminal actin-
binding domain, a PP1-binding domain, a PSD-95/discs large/zona occludens-1 (PDZ) 
domain, and a C-terminal coiled-coil region (Sarrouilhe, di Tommaso, Metaye, & 
Ladeveze, 2006). Looking closer at the PP1 binding domain reveals the fact that the 
primary binding site of PP1 on spinophilin is localized between amino acids 417-494, 
which contains a pentapeptide motif (R/K-R/K-V/I-X-F). This motif is between amino 
acids 447-451 and is conserved in other PP1 regulatory subunits (M. Bollen, 2001). 
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 Spinophilin binding to F-actin anchors a pool of PP1 to the PSD, where it regulates 
glutamatergic neurotransmission and plasticity (Allen et al., 1997; Feng et al., 2000; Satoh 
et al., 1998; Yan et al., 1999). Spinophilin targets PP1 to specific neuronal substrates 
(Grossman et al., 2004; Ragusa et al., 2010; Sarrouilhe et al., 2006; Terry-Lorenzo et al., 
2002). Spinophilin not only targets PP1 to dephosphorylate various substrates, but it can 
also inhibit PP1 activity towards certain substrates by binding tightly to PP1 and not 
allowing it to dissociate from spinohilin (Mathieu Bollen et al., 2010; Ragusa et al., 2010). 
Various proteins have been shown to interact with spinophilin such as CaMKII. 
Spinophilin can interact with CaMKII and may play a role in targeting the CaMKIIα 
isoform to F-actin (Baucum et al., 2012; L. C. Carmody, A. J. Baucum, M. A. Bass, & R. 
J. Colbran, 2008; Terry-Lorenzo et al., 2005). Moreover, spinophilin can interact with F-
actin and this interaction is modulated by spinophilin phosphorylation at the N-terminal, 
F-actin binding domain (Feng et al., 2000; Grossman et al., 2004; Hsieh-Wilson et al., 
2003). Since both actin (Cingolani & Goda, 2008) and spinophilin are enriched in dendritic 
spines (Bordelon et al., 2005), their interaction may affect spine structure. Specifically, 
their interaction has been shown to affect spine maturation, synaptic plasticity, and spine 
maintenance (Feng et al., 2000; Nakanishi et al., 1997; Zito, Knott, Shepherd, Shenolikar, 
& Svoboda, 2004). One other study supports this and suggests that spinophilin aids in 
binding F-actin to the cell membrane (Satoh et al., 1998). Additionally, ion channels and 
various receptors such as NMDA and AMPA receptors are known to interact with 
spinophilin. The GluR1 subunit of the AMPAR (Yan et al., 1999) and GluN2B subunit of 
the NMDAR interact with spinophilin (Baucum et al., 2012). Moreover it is shown that 
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spinophilin can modulate glutamate receptor function through its PP1 targeting role (Hu et 
al., 2015; D. W. Li et al., 2006; Yan et al., 1999) 
 As stated above, spinophilin interacts with multiple synaptic proteins such as PP1, 
F-actin, NMDAR, AMPAR, and CaMKII. These interactions may affect normal synaptic 
function and spine morphology. Consistent with this hypothesis, studies using spinophilin 
knockout mice report that spinophilin is essential to normal spine structure and function 
(Allen et al., 1997) since a significant increase in spine density and alteration in filopodia 
formation is observed in spinophilin KO mice (Feng et al., 2000). Contrarily, spinophilin 
knockdown in hippocampal cultures causes decreases in dendritic spine density (Evans, 
Robinson, Shi, & Webb, 2015). Furthermore, spinophilin KO mice experience altered LTD 
(Allen et al., 2006), which, along with LTP, is considered to be essential for synaptic 
plasticity.  
 A decrease in PP1 activity is observed as a result of 6-OHDA lesion of the 
substantia nigra, an animal model of PD. This attenuation in activity can possibly be a 
result of an altered spinophilin interaction with PP1 (Ragusa et al., 2010). Interestingly, the 
PP1-spinophilin association is increased in a rat model of PD (Brown, Deutch, & Colbran, 
2005). From these studies, it can be inferred that spinophilin interacts with multiple 
synaptic proteins in MSN dendrites, potentially playing a role in synaptic connectivity, 
plasticity and spine formation. 
 Hypotheses 
Taken together, these data suggest that NMDAR/spinophilin association may be 
important in proper synaptic formation, functionality, and post-synaptic signaling. 
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Previous data, discussed above, (Baucum et al., 2012) show that NMDAR and spinophilin 
associate both in hippocampal and striatal lysates. 
Phosphorylation of the NMDAR is very important in modulating its channel 
conductance and activity, which in turn affects post-synaptic signaling events, and brain 
function. Also, there are changes in phosphatase activity in animal models of PD. Our 
preliminary data demonstrate that spinophilin phosphorylation at a PKA and CDK5 site 
are enhanced in 6-OHDA lesioned animals, while spinophilin’s association with both 
GluN1 and GluN2B subunit of NMDAR is decreased. Furthermore, NMDAR 
phosphorylation in a rat model of PD is decreased. Given the above background, we 
hypothesize that kinase activity may modulate the spinophilin/NMDAR interaction and that 
spinophilin targets PP1 to the NMDAR to regulate NMDAR phosphorylation and function. 
Given spinophilin’s role as a synaptic scaffolding protein, it may also regulate NMDAR 
localization at synaptic and extrasynaptic sites. Consequently, alterations in spinophilin 
interactions may underlie pathologies associated with various neurodegenerative diseases, 
including PD. Overall, in this thesis, we have begun to characterize the 
spinophilin/NMDAR interaction and elucidate mechanisms that regulate this association. 
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2 METHODS 
 
 
 Generating DNA Constructs 
 Templates 
In order to generate epitope-tagged forms of the synaptic proteins used in these 
studies, we first amplified cDNAs for spinophilin, GluN1, GluN2B, PKAc, CDK5, the 
CDK5 activator, p35, and the γ1 isoform of PP1 (PP1γ1). Templates used were: human 
spinophilin (a gift from Dr. Maria Vivo, University of Naples “Federico II”), mouse GluN1 
(pCS6(BC039157); Transomic Technologies, Huntsville, AL), human GluN2B 
(BC113618; Transomic Technologies), human PKAc - pDONR223-PRKACA, human 
CDK5 - pDONR223-CDK5, p35 - pDONR223-CDK5SR1 (PKAc, CDK5, and p35 were 
gifts from William Hahn & David Root (Johannessen et al., 2010) (Addgene plasmid #s 
23495, 23699, and 23779), and rat PP1γ1 (L. C. Carmody, A. J. Baucum, M. A. Bass, & 
R. J. Colbran, 2008). 
 
 PCR Reactions 
PCR primers for the above cDNAs containing attB sites and either Shine-Dalgarno 
and Kozak sequences (for production of C-terminal tagged proteins), or a stop codon (for 
N-terminal tagged proteins) were synthesized. To create PCR products, PCR amplification 
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was performed using either Q5 DNA polymerase (New England Biolabs, Ipswich, MA) or 
VAPRase DNA polymerase (Vanderbilt University Medical Center, Nashville, TN), using
manufacturers’ recommendations. The PCR conditions were as follows: 1) a 2-minute 
initial denaturation at 98°C, 2) a 30-second denaturation at 98°C, 3) a 10-second annealing 
reaction at a primer-specific gradient temperature (see below), and 4) a 4-minute extension 
period at 72°C. Steps 2-4 were repeated 30 times for standard reactions. Annealing 
temperature was varied using a gradient with multiple ranges according to specific melting 
points of oligonucleotides (gradient usually ranged from 60-75°C). A final elongation step 
of 12 minutes was performed at 72°C. PCR products were mixed with 6x DNA loading 
dye (New England Biolabs) and separated on 1% agarose gels containing SYBR Safe (Life 
Technologies, Carlsbad, CA). Electrophoresis was performed for ~40-45 minutes at 80V. 
Amplification of the correct size DNA was confirmed by the appearance of a band of the 
appropriate size (e.g. 2445 base pairs for full-length spinophilin). Bands were subsequently 
excised from the gel and DNA was isolated using a DNA gel extraction kit (Zymo 
Research, Irvine, CA or ThermoFisher Scientific, Waltham, MA). DNA was generally 
eluted in molecular biology grade deionized water or Tris-EDTA (TE) buffer. The 
concentration was then quantified using the BioTek Cytation 3 system (BioTek 
Instruments, Inc. Winooski, VT). All vectors were then sequence verified (GENEWIZ, 
Inc., South Plainfield, NJ). 
 Gateway BP Cloning 
The PCR product for each DNA construct was combined with donor vector (pDONR 
221) using BP Gateway cloning technology from Life Technologies. The PCR product (20-
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50 fmol) was used in each reaction along with 150 ng of plasmid vector and BP Clonase II 
enzyme mixture. Reactions were performed for 1 hour to overnight at 25°C according to 
manufacturer’s protocol. Mixtures were then treated with proteinase K at 37°C for 10 
minutes. Transformation was then carried out by use of 10 µL of reaction mixture to 
transform DH5α competent E. coli from New England Biolabs. Cells were plated on Luria 
broth (LB) agar with kanamycin antibiotic and incubated overnight at 37°C. Individual 
bacterial colonies were picked and placed into 8mL liquid LB cultures with kanamycin and 
incubated overnight at 37°C with shaking. 
The next day, cells were centrifuged for 15 minutes at 4000 x g and lysed. DNA 
purification from the lysate was performed using miniprep purification kits (Zymo 
Research or Thermo Scientific). The concentration of DNA was then quantified using the 
BioTek Cytation 3 system (BioTek Instruments, Inc.). A diagnostic digestion was then 
performed on 0.5-2 µg of the resulting DNA using appropriate restriction enzymes and 
then separated on a 1% agarose gel for validation of proper insertion. Gels were imaged on 
a Bio-Rad Gel Doc EZ (Bio-Rad Laboratories, Inc. Hercules, CA). Successful BP 
recombination was confirmed by appearance of appropriate bands and samples were then 
further validated by sequencing (GENEWIZ, Inc). Sequence verified samples were used 
for LR recombination.  
 Gateway LR Cloning 
LR recombination was used to generate proteins with different epitope tags. For 
mammalian protein expression, pcDNA3.1 destination vectors with either HA, V5, myc, 
or FLAG tags were used. LR reactions were performed using manufacturer’s 
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recommendation. Specifically, 150ng of donor vector containing the intended DNA was 
incubated with 150 ng of the appropriate destination vector, at 25°C for 1 hour. LR reaction 
was then followed by Proteinase K digestion at 37°C for 10 minutes. Competent DH5α E. 
coli were transformed with 1-5 µL of the reaction mixture. The cells were then plated on 
LB-containing plates in the presence of ampicillin and incubated at 37°C overnight.  
Bacterial colonies were excised after overnight growth and cultured in 8mL liquid 
LB cultures with ampicillin. DNA was then extracted as described above and confirmed 
via restriction digest. If appropriate DNA banding patterns were present, additional 
bacterial colonies were selected from the plate and were cultured in larger (50-250 mL) 
cultures for maxipreps (Zymo Research or Thermo Scientific). DNA was re-screened via 
restriction digestion. All original empty DNA vectors used in BP or LR cloning were 
obtained from Life Technologies. 
 Mutagenesis PCR 
In order to generate point mutations, mutagenesis reactions were performed using 
QuikChange site-directed mutagenesis (Agilent Technologies, Santa Clara, CA). Reactions 
were carried out using Q5 DNA buffer and 1µl DNA polymerase in the presence of 5 µM 
DNTPs and 10 ng of template DNA. The following reaction protocol was performed: 1) an 
initial denaturation of 98°C for 2 minutes, 2) a 45-second denaturation at 98°C, 3) a 1-
minute annealing reaction at a primer-specific temperature, 4) a 15-minute elongation at 
68°C. Steps 2-4 were repeated 18 times. To eliminate template DNA, 10 µl of each reaction 
mixture was digested using 1µL of DpnI for ~2 hours at 37°C. Each mixture was then 
incubated with 6X loading dye and separated on a 1% agarose gel. If a high-intensity (i.e. 
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equal to or greater than the DNA ladder), proper molecular weight band was visualized, 
then 1 µL of the PCR product was transformed in competent DH5α-derived E. coli. Vectors 
were then sequence verified (GENEWIZ, Inc.) for the mutation.  
 Mammalian Protein Expression 
Human embryonic kidney cells (HEK293) were used for mammalian protein 
expression. Cells were typically stored long-term in liquid nitrogen and thawed at 37°C 
when needed. Cell incubation and growth was performed in Dulbecco’s modified Eagle’s 
medium (DMEM) that contained 10% FBS, 584 mg/L L-glutamine, 1mM Sodium 
Pyruvate, 100 U/mL penicillin and 100µg/mL streptomycin. 50mm culture flasks were 
incubated at a constant 37°C and 5% CO2 (Panasonic Healthcare; Secaucus, NJ).  
Cells were counted and approximately 1,000,000 cells were plated into 25 mm flat-
bottomed culture flasks and left for overnight growth. Typically, cells were transfected the 
next day at ~70-80% confluency. Confluency was measured by estimating cell coverage 
on the bottom of the flask. Depending on expression level of each protein, an appropriate 
amount of DNA was transfected (0.5 - 5 µg per DNA). The appropriate amount of DNA 
was added to 250 µL of serum-free DMEM in a 1.7mL microcentrifuge tube. In a separate 
microfuge tube, transfection reagent (Lipofectamine ,Life Technologies or PolyJet reagent 
SignaGen Laboratories Rockville, MD) was added to an additional 250 µL of serum-free 
DMEM. Polyjet and Lipofectamine were both used in a 3:1 volume:mass ratio (e.g. 18 µL 
of Polyjet was used with 6 µg DNA). For each experiment, DNA concentrations were 
equalized using an empty DNA vector, so that each condition in the same experiment had 
an equal mass of DNA and equal amount of transfection reagent. The transfection reagent 
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containing mixture was then added to the tube containing DNA and incubated at room 
temperature for 15 minutes. The entire mixture was then added to the proper flask and cells 
were incubated overnight.  
Following overnight incubation, cell adherence to flask bottoms was examined. If 
there was little to no disruption of adherence of the cells, the DMEM was aspirated off and 
cells were washed with 6mL of cold phosphate-buffered saline (PBS). PBS was aspirated 
off and cells were lysed in 1.5 mL KCl lysis buffer then transferred into 2 mL 
microcentrifuge tubes. If a high percentage of cells were unattached, they were re-
suspended in DMEM, then transferred to 15 mL centrifuge tubes and centrifuged at 250 x 
g for 5 minutes. After aspiration of media, 6 ml of cold PBS was added to cells and the 
pellet triterated, which was followed by an additional centrifugation. PBS was then 
aspirated and cells were lysed in KCl lysis buffer (150 mM KCl, 1 mM DTT, 2 mM EDTA, 
50 mM Tris-HCl pH 7.5, 1% (v/v) Triton X-100, 20 mM NaF, 20 mM β-glycerophosphate, 
20 mM NaVO3, 10 mM Na pyrophosphate, 1X Halt protease inhibitor cocktail; Thermo 
Scientific Waltham, MA). Cells were sonicated at 25% amplitude for 15 seconds at 4°C 
using a probe sonicator (Thermo Scientific) and centrifuged (4°C for 10 minutes at 14,000 
x g). Cell lysates were then used for immunoprecipitations. 
 Tissue Homogenization 
Male or female, WT, C57Bl6 or spinophilin knockout mouse (Jackson laboratories, 
Bar Harbor, ME) brains were dissected. Forebrain tissue was flash-frozen in liquid 
nitrogen. Half of frontal cortex was homogenized in 2mL of isotonic RIPA buffer 
containing 1% Triton X-100 buffer using fifteen up-and-down movements of a pestle in a 
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2 mL tight-fitting glass homogenizer. Tissue homogenate was then transferred to a 2 mL 
microcentrifuge tube and processed in the same manner as HEK293 cells described above. 
Tissue was then brought up to 4 mL using the RIPA buffer. IP pulldowns were then 
performed as described below. 
 Immunoprecipitations (IPs) 
HEK293 cell lysate or brain homogenate were transferred to a microcentrifuge tube 
for IPs (400-500 µl) or for a total input (75 µl). For the input, 25 µL of 4X sample buffer 
(0.2 M Tris HCl pH 6.8, 40% glycerol, 0.1 M DTT, 8% SDS w/v, 0.04% bromophenol 
blue w/v in water) was added to each input sample, vortexed and stored at -20°C. For the 
IPs, the appropriate IP antibody was added and incubated at 4°C for approximately 1 hour. 
Antibodies used for IPs were: rabbit monoclonal anti- spinophilin (E1E7R, 14136, Cell 
Signaling technology, INC.), goat polyclonal anti-Neurabin II (A-20, SC14774, Santa Cruz 
Biotechnology, INC.), rabbit monoclonal anti-NMDAR2B (D15B3, 4212, Cell Signaling 
technology, INC.) goat polyclonal anti-V5 tag (A190-119A, Bethyl Laboratories, Inc.), 
rabbit polyclonal anti V5 tag (D3H8Q, 13202, Cell Signaling technology, INC.), goat 
polyclonal anti-HA tag (A190-107A, Bethyl Laboratories, Inc. Montgomery, TX), goat 
polyclonal anti-Myc tag (A190-104A, Bethyl Laboratories, Inc. Montgomery, TX), and 
mouse polyclonal anti-PP1 (E-9, sc-7482, Santa Cruz Biotechnology, INC.). After 1-hour 
incubation of IP antibodies with samples, 30 µL of protein G magnetic beads that had been 
previously washed in IP buffer (50 mM Tris HCl, 150 mM NaCl, 0.5% Triton X-100) was 
added to each sample and incubated rotating overnight at 4°C.  
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Following incubation, samples were magnetically separated and washed three 
times with IP wash buffer. Then 40 µL of 2x sample buffer (4x buffer diluted 1:2 with 
Milli-Q water) was added to each of the samples, vortexed and stored at -20°C until they 
were analyzed by western blot. 
 SDS-PAGE and Western Blotting 
Cell lysates or protein IPs were then used for western blotting. All samples were 
heated at 70°C for 10 minutes, then IP samples were placed on a magnet prior to loading 
in order to separate magnetic beads out of suspension. 5 µL of each input and 10 µL of 
each sample was loaded onto a 26-well, pre-cast Criterion 4-15% polyacrylamide gradient 
gel (Bio-Rad), a 15 well 4-15% Mini-Protein TGX polyacrylamide gradient gel (Bio-Rad), 
or a 1.5 mm hand-cast 10% polyacrylamide gel. Hand-cast gels were generally run at 75 V 
for 15 minutes and 175 V for approximately 1 hour and the precast gels were run typically 
at 165 V for 1 hour. Proteins were transferred to nitrocellulose membranes using one of 
two transfer methods. 
For a full wet transfer, proteins were transferred to a nitrocellulose membrane using 
an N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) transfer buffer (10% MeOH, 0.01 
M CAPS pH 11). The transfer was performed in a transfer tank attached to a water-cooling 
unit set at 2.5-4°C and transfer occurred at a constant 1.0 Amps for 1.5 hours.  
For semi-dry transfer, a Trans-Blot Turbo was used. Gels were transferred to 
nitrocellulose using a cold TransBlot Turbo transfer buffer with 20% ethanol. Transfers 
were performed using the TransBlot Turbo system (Bio-Rad) at a voltage of 9V for 30 
minutes.  
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After transferring, membranes were placed in blotting boxes. An optional Ponceau 
S stain for 10 minutes was often used to confirm protein transfer and to evaluate equal 
loading. Following staining, membranes were washed with deionized water and scanned. 
Membranes were blocked using 5% (w/v) nonfat dry milk in 0.1% (v/v) Tween-20 in 1 M 
Tris-buffered saline pH 7.5 (TBST). Blocking was performed 3 times, 10 minutes each, for 
total of 30 minutes. After the final blocking step, the TBST-milk was replaced with primary 
antibodies diluted in 5% milk in TBST and incubated overnight at 4°C with shaking. 
Primary antibodies used were: a rabbit polyclonal anti-V5 (G-14, sc-83849, Santa Cruz 
Biotechnology, INC), a goat polyclonal anti-HA (A190-107A, Bethyl Laboratories, Inc. 
Montgomery, TX), a goat polyclonal anti-PP1γ (sc-6108 Santa Cruz Biotechnology), a 
mouse monoclonal anti-PP1 α (E-9, sc-7482, Santa Cruz Technology, INC), a rabbit 
polyclonal anti phosphor-NMDAR2B-Ser1284 (5355, Cell Signaling Technology) and a 
mouse monoclonal anti-Myc (9E10, sc-40, santa Cruz Technology, INC). After incubation, 
membranes were washed 3 times for 10 minutes per wash with TBST containing 5% milk. 
Following the washes, appropriate secondary antibodies were added to the membranes. 
Secondary antibodies used were: Alexa Fluor 790-conjugated AffiniPure Donkey Anti-
Mouse IgG (Jackson ImmunoResearch Laboratories, INC.), Alexa Fluor 790-conjugated 
AffiniPure Donkey Anti-Rabbit IgG (Jackson ImmunoResearch Laboratories, INC.), 
Alexa Fluor 790-conjugated AffiniPure Donkey Anti-Goat IgG (Jackson ImmunoResearch 
Laboratories, INC.), Alexa Fluor 680-conjugated donkey anti-Goat (Molecular Probes, 
Invitrogen detection technologies) and Alexa Fluor 680-conjugated donkey anti-Rabbit 
(Molecular Probes, Invitrogen detection technologies). Jackson ImmunoResearch 
antibodies were typically diluted 1:50000 in 5% milk and Invitrogen antibodies were 
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generally diluted 1:10000 in 5% milk. Secondary antibodies were incubated with 
membranes for 60 minutes at room temperature in darkness with shaking. After proper 
incubation, secondary antibodies were discarded and membranes were washed three times 
with Tris-Buffered saline without Tween for 10 minutes in each wash. Fluorescence scans 
were performed using the Odyssey imaging system and data analysis was done using Image 
Studio software (LiCor, Lincoln, NE).  
 In-vitro Kinase Activation 
To activate endogenous PKA in HEK293 cells, 500 µM forskolin in 
dimethylsulfoxide (DMSO), and 5 mM 3-isobutyl-1-methylxanthine (IBMX) were used. 
After transfection and overnight incubation, DMEM was removed and replaced with 
DMEM containing forskolin and IBMX (1:1000 dilution) or vehicle alone. Cells were then 
incubated for 1 hour for short-term activation or for 24 hours for long-term activation. At 
the end of incubation, cells were processed immediately as described above. 
 Mass Spectrometry 
Samples collected from SDS-PAGE were digested using trypsin and analyzed by 
mass spectrometry. All the samples were analyzed in the laboratory of Dr. Lisa Jones, 
Department of Chemistry and Chemical Biology, IUPUI. Raw data from mass 
spectrometry were searched against the human database using Mascot algorithm and 
Proteome Discoverer (Thermo Scientific). Magellan Storage output files (MSF) were 
imported into Scaffold 4 (Proteome Software, Portland, OR). MS/MS spectra of tryptic 
fragments matching specific phosphorylation sites were validated and the area under the 
curve (AUC) of the extracted ion chromatogram (XIC) was calculated for the 
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phosphorylated peptide. These AUCs of the XICs were normalized to a control, non-
phosphorylated peptide AUC of the XIC to create a phosphorylation ratio. The generated 
ratios were compared across different groups, as previously described (Baucum, Shonesy, 
Rose, & Colbran, 2015).  
 Statistical Analyses 
Image Studio software was used for quantification of the integrated fluorescence 
intensities detected in the western blots. To calculate associations, we divided the 
integrated fluorescence intensity for the co-immunoprecipitated protein by the integrated 
fluorescence intensity for the immunoprecipitated protein. In order to normalize for any 
differences in protein expression, we took the above normalized value and divided it by 
the input value for the co-immunoprecipitated protein. To compare different conditions 
across gels, we normalized the above ratio from the experimental condition by the ratio 
generated on the same gel for a control condition. As an example, to determine if PKA 
overexpression modulates the association between spinophilin and GluN2BTail, we 
performed the following measurements and calculations. First, we divided the fluorescence 
intensity of the V5-tagged GluN2B protein that is present in the HA-tagged spinophilin 
immunoprecipitates by the fluorescence intensity of the HA-tagged spinophilin in these 
same IPs. We would then normalize this value to the fluorescence intensity of the V5-
tagged GluN2B protein that is expressed in the input sample. This calculation would be 
performed for both the sample without PKA overexpression and the sample with PKA 
overexpression. The value from the PKA-containing sample would then be divided by the 
PKA-absent sample to generate a ratio. The formula for this ratio is 
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EXPERIMENTAL((Intensity co-IP proteinPrecipitate/Intensity IP proteinPrecipitate)/(Intensity 
co-IP proteininput))/CONTROL((Intensity co-IP proteinPrecipitate/Intensity IP 
proteinPrecipitate)/(Intensity co-IP proteininput)). This ratio was averaged across multiple 
transfections, with each transfection corresponding to a unique biological replicate. The N 
values for each individual experiment correspond to the number of unique biological 
replicates. To compare between groups, a one-column t-test was performed to compare the 
experimental to a theoretical value of 1. If more than two groups were compared, a one-
way ANOVA was used to determine significance. This was followed by a Tukey-posthoc 
test. Where appropriate, a two-way ANOVA was used to compare across two different 
treatment conditions (e.g. Figure 10)
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3 RESULTS 
 
 
 Spinophilin Associates with GluN1 in a Heterologous Cell System 
Studies show that GluN1 subunits are obligatory subunits necessary for functional 
expression of the NMDA receptors (S. Cull-Candy et al., 2001). The PDZ domain of 
spinophilin can associate with multiple subunits of the NMDA receptor such as GluN1 and 
GluN2B (Baucum, Brown, & Colbran, 2013; Kelker et al., 2007). A recent proteomics 
study identified changes in multiple synaptic proteins isolated from spinophilin 
immunoprecipitates from mice with a 6-OHDA lesion of the substantia nigra (Hiday and 
Edler et al., Manuscript in preparation). Specifically, the association of GluN1 and GluN2B 
following 6-OHDA lesion is decreased following lesion. However the mechanisms that 
modulate the spinophilin/NMDAR interaction are unclear. To further study the 
GluN1/spinophilin interaction, we aimed to use a heterologous cell system. Consequently, 
we overexpressed V5-tagged GluN1 in a HEK293 cell system alongside HA-tagged 
spinophilin. 48-hours post transfection, cells were lysed using KCl buffer. Immunoblot 
results show an interaction between spinophilin and GluN1 in HEK293 cells in both GluN1 
and spinophilin immunoprecipitates (Figure 1). 
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 Spinophilin Associates with the GluN2B subunit of NMDARs in mouse brain 
lysates and with C-terminal tail of GluN2B Subunit of NMDAR in HEK293 Cells 
Recent data have shown that spinophilin and GluN2B subunit of NMDAR co-
immunoprecipitate from striatal lysates (Baucum et al., 2013). To further probe the 
interaction between spinophilin and GluN2B, we immunoprecipitated spinophilin or 
GluN2B from brain lysates. Our results show that spinophilin pulls down GluN2B subunit 
of NMDAR along with it. Moreover, we were able to detect spinophilin in GluN2B IPs 
(Figure 2A). To further investigate the specificity of this interaction, we used spinophilin 
knockout mice and performed spinophilin and GluN2B IPs from spinophilin KO mice 
brain. Two different spinophilin antibodies (Goat polyclonal and rabbit monoclonal) were 
used for spinophilin IP. Results show no spinophilin band in inputs suggesting a successful 
spinophilin knockout. Additionally, IP of spinophilin from mice brain, did not bring down 
any GluN2B along with it, suggesting that the interaction observed between spinophilin 
and GluN2B in previous experiment is specific (Figure 2B). Furthermore, since it is easier 
to manipulate, we used heterologous cell system to further study of the interaction in 
HEK293 cells. For this purpose, we first wanted to determine where spinophilin binds to 
the GluN2B subunit of the NMDAR. GluN2B alone cannot traffic to the membrane and 
tends to become trapped in the ER (Das et al., 1998); however, the C-terminal intracellular 
tail domain of human GluN2B (GluN2BTail; amino acids 839-1484) is not trapped in the 
ER and is localized to the cytosol. To determine if spinophilin interacts with the 
GluN2BTail, HA-tagged spinophilin and V5-tagged GluN2BTail were overexpressed in a 
heterologous cell line (HEK293FT cells) and subsequently immunoprecipitated. Both 
inputs and immunoprecipitates were separated by SDS-PAGE and immnoblotted for 
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GluN2BTail and spinophilin. We detected GluN2BTail in spinophilin immunoprecipitates 
and spinophilin in GluN2BTail immunoprecipitates (Figure 3).  
 Spinophilin Interacts with GluN2B Residues 839-1088 
Given the robust interaction between spinophilin and the C-terminal tail of GluN2B, we 
wanted to specify the motif on the GluN2BTail that interacts with spinophilin. We generated 
V5-tagged GluN2BTail fragments containing amino acids 839-1088, 1038-1484 and 1268-
1484. HEK293 cells were transfected with V5-tagged GluN2BTail fragments and HA-
tagged spinophilin. Since the expression level of the fragments was not robust, we also 
transfected 1µg of Myc-tagged PKA in all the conditions (see below). Cells were lysed 24-
hours post transfection and samples were submitted to SDS-PAGE. Qualitative data show 
a robust interaction of HA-tagged spinophilin with the first fragment of GluN2BTail, 839-
1088 (Figure 4). We also intended to identify the domains of spinophilin that interact with 
GluN2BTail. For that purpose we generated different spinophilin fragments; however, we 
could not identify specific fragments that associate with GluN2BTail suggesting that a larger 
piece or the full-length spinophilin protein is required for interaction (Data not shown).  
 Overexpression of PKA in HEK293 Cells Increases Spinophilin and NMDAR 
Interaction 
Previous studies from the laboratory have demonstrated that dopamine depletion 
decreases the association between spinophilin and the NMDAR (Hiday and Edler et al., 
Manuscript in preparation). Dopamine depletion modulates protein kinase A (PKA) 
activity in striatal MSNs. As mentioned previously, phosphorylation of PKA sites on 
spinophilin are increased in an animal model of PD (Hiday and Edler et al., Manuscript in 
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preparation). Therefore, we aimed to determine if the catalytic subunit of PKA (PKAc) can 
directly regulate the interaction between spinophilin and the NMDAR. V5-tagged GluN1 
or V5-tagged GluN2BTail and HA-tagged spinophilin were co-expressed in HEK293 cells 
alone or alongside myc-tagged PKAc. Qualitatively, results show a robust increase in the 
association between spinophilin and GluN1 in the presence of PKAc (Figure 5A). There 
was a trend for an increase in spinophilin isolated from the GluN1 IPs, P value = 0.07 
(Figure 5C). Moreover, GluN1 levels were significantly increased in spinophilin IPs 
(Figure 5B).  
Overexpression of PKAc also increased the association of spinophilin and 
GluN2BTail (Figure 6A). Quantified data show a significant increase of GluN2BTail in the 
spinophilin IP (Figure 6B) as well as spinophilin in the GluN2BTail IP (Figure 6C) in the 
presence compared to the absence of overexpressed PKAc. 
 Long-term Activation of Endogenous PKA Increases the Interaction between 
Spinophilin and the NMDAR 
To further validate a catalytic role of PKA in modulating the spinophilin/NMDAR 
association, we measured the interaction of spinophilin and the NMDAR when endogenous 
PKA was activated. IBMX and forskolin were used to pharmacologically activate 
endogenously expressed PKA in HEK293 cells over a period of 16-20 hours. V5-tagged 
GluN1 or V5-tagged GluN2BTail were transfected alone or together with HA-tagged 
spinophilin and cells were incubated for 24 hours. Then the cells were treated with 
IBMX/forskolin in DMSO or in DMSO alone for another 24 hours to activate PKA. 
Qualitatively, long-term activation of PKA increased the spinophilin-GluN1 interaction 
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(Figure 7A). Quantified data show a significant increase in levels of GluN1 in HA IPs when 
normalized to GluN1 in the inputs (Figure 7B). V5 IPs were not quantified due to 
background fluorescence. As with GluN1, activation of endogenous PKA increased the 
association of spinophilin with GluN2BTail (Figure 8A). Quantitatively, GluN2BTail and 
spinophilin levels were significantly increased in the HA and V5 IPs, respectively (Figure 
8B, 8C). All the values were normalized to levels of non-immunoprecipitated inputs (See 
methods for description of quantification). Normally, the NMDAR is organized with two 
GluN1 and two GluN2 subunits. In order to have a better understanding of the effect of 
PKA on the association of spinophilin with a functional NMDAR, V5-tagged GluN1, Myc-
tagged GluN2B and HA-tagged spinophilin were co-expressed in a heterologous cell 
system with or without endogenous PKA 24-hour activation. Results suggest an increase 
in the association of GluN1-GluN2B complex with spinophilin when accompanied with 
PKA overexpression (Figure 9). 
 Overexpression of CDK5 in HEK293 Cells Decreases Spinophilin and GluN2BTail 
Interaction 
In addition to PKA, CDK5 activity is known to be regulated in animal models of 
PD. We found that spinophilin phosphorylation at Ser17, a CDK5 site (Futter et al., 2005), 
was increased in an animal model of PD (Hiday and Edler et al., manuscript in preparation). 
To determine the effect of CDK5 on modulating the spinophilin/GluN2Btail association, 
V5-tagged GluN2BTail and HA-tagged spinophilin were co-expressed in HEK293 cells 
alone or alongside FLAG-tagged CDK5 and the CDK5 activator, p35. Quantitatively, there 
was a robust decrease in the association between spinophilin and GluN2Btail in the presence 
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of CDK5 (Figure 10A-B). V5 IPs were not quantified due to low expression levels in the 
co-IP.  
 Phosphorylation of Ser17 on Spinophilin is not Responsible for the Decrease in 
Spinophilin- GluN2BTail Interaction 
As previously mentioned, CDK5 decreases spinophilin-GluN2BTail interaction. Studies 
show that CDK5 can phosphorylate multiple sites on spinophilin and GluN2B. For 
instance, Serine 17 on spinophilin (Futter et al., 2005) and Serine 1284 on GluN2B are 
CDK5 phosphorylation sites (W. Lu et al., 2015). Together, these data suggest that 
phosphorylation on either S17 or spinophilin or S1284 on GluN2B regulate spinophilin-
GluN2B interaction. To begin to test this hypothesis, we generated phospho-mimetic 
(S17D) and phospho-deficient (S17A) mutants of spinophilin. Ser to Ala and Ser to Asp 
mutants cannot be phosphorylated (Ala) or mimic a charged (i.e. phosphorylated) form 
(Asp) of a protein (Bornancin & Parker, 1997). In order to investigate the effect of S17 
mutation on spinophilin-GluN2BTail association, S17A and S17D mutants along with 
GluN2BTail were overexpressed in HEK293 cells in presence or absence of over expressed 
CDK5. Results suggest that, S17 phosphorylation alone does not have an effect on the 
association. Moreover, the S17A mutant when accompanied with CDK5 overexpression 
still has a decreased association with GluN2B. Two-way ANOVA shows a significant 
effect of CDK5 overexpression (P<0.0001) while no significant effect of S17 genotype 
was observed (Figure 11A, B). 
 
35 
 
  
 Overexpression of CDK5 in HEK293 Cells Increases Spinophilin and PP1 
Interaction 
Given the PP1 targeting role of spinophilin, modulating the spinophilin/PP1 
association may also have implications in substrate phosphorylation. Recent studies 
indicate that PP1 can be phosphorylated by CDK5 on Thr320, which is known to have an 
inhibitory role on PP1 activity (Hou et al., 2013). As indicated previously, spinophilin is 
also known to be phosphorylated by CDK5 (Futter et al., 2005). As a consequence we 
intended to look at the effect of CDK5 on the PP1/spinophilin association. We 
overexpressed HA-tagged spinophilin in HEK293 cells along with FLAG-tagged CDK5 
and Myc-tagged P35. We did not overexpress PP1 since PP1 is robustly expressed in 
HEK293 cells. Lysates were immunoprecipitated for HA (spinophilin). IPs were blotted 
for PP1 or spinophilin. Qualitatively, there was a robust increase in the association between 
spinophilin and PP1 in the presence of CDK5 (Figure 12A). Quantitative measurements 
showed a three-fold increase in the PP1-spinophilin association in presence of CDK5 
(Figure 12B).  
 Spinophilin Decreases the Association of PP1 with GluN2BTail 
Spinophilin is known to regulate NMDAR function as spinophilin KO mice have 
altered NMDAR kinetics (Allen et al., 2006; Feng et al., 2000). Moreover, spinophilin is 
known to bind to PP1 to alter its targeting to specific substrates. To identify potential 
mechanisms by which spinophilin modulates the PP1/NMDAR interaction, we evaluated 
PP1 levels in GluN2BTail immunoprecipitates. V5-tagged GluN2BTail and Myc-tagged 
PP1γ1 were co-overexpressed in HEK293 cells in presence and absence of overexpressed 
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HA-tagged spinophilin. Lysates were immunoprecipitated with the appropriate antibody 
(see methods). Results revealed that PP1γ1 associated with GluN2BTail in the absence of 
spinophilin, suggesting that PP1 can associate with GluN2BTail directly or via a HEK-cell 
expressed targeting protein (Figure 13A). In contrast to a putative role for spinophilin 
targeting PP1 to the NMDAR, overexpression of spinophilin dramatically decreased the 
abundance of PP1 bound to GluN2BTail (Figure 13A). This suggests that spinophilin traffics 
PP1 away from GluN2BTail or that spinophilin can displace PP1 directly from GluN2BTail. 
While spinophilin can associate with GluN2BTail, only a very small fraction is probably 
bound. Quantified data demonstrate a ~84% decrease in the levels of PP1γ1 in the 
GluN2BTail immunoprecipitates (Figure 13B). Consistent with this, there was a ~75% 
decrease in the levels of GluN2BTail in the PP1γ1 immunoprecipitates (Figure 13C).  
 Overexpression of PP1 Binding Deficient Mutant Spinophilin (F451A) Does Not 
Affect PP1 Binding to GluN2BTail 
The spinophilin-dependent regulation of GluN2BTail binding to PP1γ1 may be due 
to either spinophilin binding to the same location on GluN2BTail where PP1γ1 is bound, or 
it could be that unbound spinophilin is competing for PP1. To test this, we utilized a PP1-
binding deficient mutant (F451A). Studies have shown that the PP1 binding motif on 
spinophilin is located between residues 447-451 and an F451A mutation of spinophilin 
abolishes the spinophilin-PP1 interaction (Hsieh-Wilson, Allen, Watanabe, Nairn, & 
Greengard, 1999). We overexpressed WT and F451A mutant spinophilin with or without 
PP1γ1 overexpression. According to our results, spinophilin association with HEK293 cell 
endogenous PP1 is completely abrogated when spinophilin in mutated at 451 residue 
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(Figure 14A), while interaction of this mutant to PP1γ1 is attenuated, but not completely 
abrogated (Figure 14B). Subsequently, HEK293 cells were transfected with V5-tagged 
GluN2BTail and Myc-tagged PP1γ1 with either HA tagged WT spinophilin or MU 
spinophilin. As in Figure 13, WT spinophilin decreased PP1 bound to GluN2BTail; 
however, F451A mutant spinophilin had no effect on the association of PP1γ1 with 
GluN2BTail (Figure 15 B). Quantitatively, there was a significant effect of spinophilin on 
the PP1γ1 association with GluN2B tail (One-way ANOVA p < 0.05). Specifically, the 
WT, but not the mutant, spinophilin caused a decreased association of GluN2BTail. This 
altered association between PP1 was not due to differences in binding of WT and F451A 
spinophilin, as if anything, the mutant form of spinophilin bound more GluN2BTail. 
 Spinophilin Rescues PP1-dependent Dephosphorylation of S1284 on GluN2BTail 
To determine functional implications of modulating PP1 targeting to GluN2BTail, we 
transfected V5-tagged GluN2BTail along with Myc-tagged PP1γ1 with and without HA-
tagged spinophilin. We also overexpressed Myc-tagged PKAc in order to enhance PKA 
phosphorylation of GluN2BTail. HEK293 cells were incubated 16-24 hours after 
transfection and were lysed using KCl buffer followed by immunoprecipitation using 
appropriate antibodies (see methods). SDS-PAGE was performed and the gel was stained 
with Coomassie Brilliant Blue protein stain. Samples were then prepared for mass 
spectrometry following the procedure explained in section 2.7. According to MS/MS 
results, several PKA phosphorylation sites were observed, some of which were previously 
known like Serine 1303 (Figure 16D) and some were identified during this experiment 
such as Serine 929/930 (Figure 16A), Serine 940 (Figure 16B), and Serine 1050 (Figure 
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16C). In addition to these sites, we identified serine 1284 on GluN2BTail, which is highly 
phosphorylated endogenously and is not sensitive to PKA expression. Interestingly, 
overexpression of PP1γ1 decreased S1284 phosphorylation on GluN2BTail (Figure 17A). 
Overexpression of PKA along with PP1γ1 does not rescue this decreased phosphorylation, 
suggesting that this is not a PKA sensitive site, consistent with other data suggesting it is a 
CDK5 site (W. Lu et al., 2015). Interestingly, co-expression of spinophilin along with PKA 
and PP1γ1 attenuated the PP1-dependent decrease in S1284 phosphorylation (Figure 17A). 
To validate that spinophilin can modulate S1284 phosphorylation, we used 
phosphorylation-specific antibodies. HEK293 cells were transfected with V5-tagged 
GluN2BTail and Myc tagged PP1γ1 in presence or absence of HA-tagged spinophilin. Cells 
were lysed 24-hours post transfection, and were separated using SDS-PAGE. Phospho-
NMDAR2B-Ser1284 antibody was used for blotting. The phospho signal in the GluN2Btail 
IP was normalized to the total NMDAR level in the GluN2Btail IP. Preliminary data (N = 
2) suggest a decrease of GluN2BTail phosphorylation at S1284 in presence of PP1. 
Moreover, spinophilin expression rescues this decrease in phosphorylation (Figure 17 B, 
C)
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4 DISCUSSION 
 
 
 Spinophilin Interacts with GluN1 and GluN2B Subunit of NMDARs and This 
Interaction is Decreased in 6-OHDA Treated Mice 
NMDARs are tetramers in which two essential GluN1 subunits with two GluN2 
and/or one GluN2 and one GluN3 subunit assemble together. GluN1 subunits are essential 
for expression of a functional channel (S. Cull-Candy et al., 2001). Studies suggest that the 
GluN1/GluN2 heterodimer is the functional unit in NMDARs. As mentioned previously, 
spinophilin can affect the phosphorylation state of various substrates by targeting PP1 to 
them (Grossman et al., 2004; Ragusa et al., 2010; Terry-Lorenzo et al., 2002) or inhibiting 
PP1 activity towards certain substrates by binding tightly to PP1 (Mathieu Bollen et al., 
2010; Ragusa et al., 2010). Therefore, we evaluated the association between spinophilin 
and various subunits of NMDARs. Previous studies have shown that spinophilin can 
interact with GluN1 and GluN2B subunit of NMDARs both in vivo (Baucum et al., 2013) 
and in vitro (Kelker et al., 2007). Preliminary data from the laboratory shows 
spinophilin/GluN1 and spinophilin/GluN2B interaction in mouse brain lysate. Moreover 
spinophilin/GluN1, spinophilin/GluN2B and spinophilin/GluN1/GluN2B interactions 
were observed in HEK293 cells where an isotonic KCl-containing buffer was used 
to mimic an isotonic brain environment. 
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6-OHDA is a chemical compound known to lesion nigral projections to striatum and 
mimic PD (Simola, Morelli, & Carta, 2007). Preliminary data from our lab suggest a 
decrease in the spinophilin/GluN1 and spinophilin/GluN2B interaction in 6-OHDA treated 
mice (Hiday and Edler et al., Manuscript in preparation). This change in interaction may 
be due to alterations in phosphorylation of spinophilin and/or the NMDAR. Previous 
studies show that application of 6-OHDA reduces NMDAR phosphorylation at some 
residues and increases its phosphorylation at other amino acids; however, the overall 
phosphorylation of GluN1 and GluN2B is strikingly increased (Dunah et al., 2000; 
Koutsokera, Kafkalias, Giompres, Kouvelas, & Mitsacos, 2014). Furthermore, spinophilin 
phosphorylation on Ser17 and Ser100 is increased in an animal model of PD (Hiday and 
Edler et al., Manuscript in preparation). All in all, DA depletion alters NMDAR and 
spinophilin phosphorylation status, which can possibly regulate the spinophilin/NMDAR 
interaction. Given the role of spinophilin in targeting PP1 to myriad substrates, the change 
in NMDAR/spinophilin interaction may have implications in the phosphorylation status of 
the NMDAR.  
 Spinophilin Interacts with Residues 839-1088 of C-Terminal Tail of GluN2B 
Subunit 
In order to further study the spinophilin/NMDAR association, we aimed to look at 
domains of the subunits that interact with spinophilin. Structurally, NMDAR subunits 
contain a number of domains including an extracellular N-terminal domain, a 
transmembrane domain, a pore loop, and a variable length, subunit-dependent, intracellular 
C-terminal tail domain. The tail region is known to regulate receptor interactions with 
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various intracellular proteins. As a result, it is a good candidate to interact with intracellular 
proteins. For this purpose, we generated a DNA construct of the tail region of GluN2B, 
which is known to have 650 amino acids and transfected it along with spinophilin. Our 
results show a robust interaction between C-terminal tail of GluN2B and spinophilin. To 
further identify the interacting domain on GluN2BTail, we generated DNA constructs 
matching portions of the Tail region. Due to low expression level of tail fragments, PKAc 
was overexpressed as we found that overexpression of PKAc enhances the association 
between the proteins. Our results suggest that there was a very robust basal association 
between spinophilin and amino acids 839-1088 of GluN2BTail in HEK293 cells.  
 PKA Enhances the Interaction of GluN1 and GluN2BTail with Spinophilin 
In order to identify the mechanisms that affect the spinophilin-NMDAR association, 
we evaluated the role of kinases on modulating the spinophilin/NMDAR interaction.  
Spinophilin has been previously shown to target PP1 to specific substrates (Allen et al., 
1997; Ragusa et al., 2010). Furthermore, 6-OHDA lesioned mice, which is used as a model 
of Parkinson disease, show an increased spinophilin phosphorylation on Serine 100 and 
Serine 17 (Hiday and Edler et al., Manuscript in preparation) which are PKA (Hsieh-
Wilson et al., 2003) and CDK5 (Futter et al., 2005) sites, respectively. These changes 
occured along with a decrease in the association of GluN1 and GluN2B with spinophilin. 
Thus, we hypothesized that enhanced phosphorylation with PKA and CDK5 may 
contribute to this decreased association. PKA has been shown in previous studies to 
phosphorylate spinophilin (Hsieh-Wilson et al., 2003), GluN1 (D. B. Scott et al., 2001) and 
GluN2B (Murphy et al., 2014). According to results, spinophilin-GluN1 and GluN2BTail -
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spinophilin interactions were increased in presence of overexpressed PKAc. However, 
details of this interaction (i.e. if PKA phosphorylation causes this increase or it has a kind 
of bridging role) are not entirely clear. In order to clarify this interaction, endogenous PKA 
was activated for 24hrs using IBMX, a phosphodiesterase inhibitor (Francis, Turko, & 
Corbin, 2001) and forskolin, an adenylyl cyclase activator (Seamon & Daly, 1981). Results 
suggest that long-term activation of PKA has the same influence on spinophilin-GluN1 and 
GluN2BTail interaction. From these results, we infer that, phosphorylation caused by PKA 
increases the interaction of GluN1 and GluN2BTail with spinophilin. However we cannot 
be certain if PKAc also has a bridging role in enhancement of this association. Taken 
together, our data demonstrate a PKA-dependent modulation of the spinophilin/NMDAR 
interaction and suggest that phosphorylation is a critical regulator of the GluN1-spinophilin 
and GluN2B-spinophilin association. Moreover, as stated previously, the decreased 
association of spinophilin and GluN1 and GluN2B in 6-OHDA treated mice, is probably 
not because of phosphorylation by PKA as, if anything, PKA actually increases the 
interaction between spinophilin and the NMDAR.  
 CDK5 Decreases the Interaction Between GluN2BTail and Spinophilin by 
Phosphorylating GluN2BTail and/or Spinophilin on a Non-Ser17 Residue 
As mentioned above, 6-OHDA lesioned mice have greater phosphorylation of 
spinophilin at Serine 17 (Hiday and Edler et al., Manuscript in preparation), a CDK5 site 
(Futter et al., 2005). In addition, GluN2B is also phosphorylated by CDK5 (W. Lu et al., 
2015). Therefore, we tested whether CDK5 activity modulates the association between 
spinophilin and GluN2B. Overexpression of CDK5 in HEK293 cells causes an overall 
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decrease in protein expression in the cells which may be due to aggregation of CDK5 
phosphorylated proteins and targeting them to ubiquitin-proteasome pathway for 
degradation. While having low expression levels of proteins, overexpression of CDK5 
decreased the association between spinophilin and GluN2B. We hypothesize that 
phosphorylation of CDK5 sensitive sites on either spinophilin and/or GluN2B are 
responsible for this result. To investigate this hypothesis, we generated S17A and S17D 
phospho- mutant isoforms of spinophilin. Results show that S17A mutant which is unable 
to be phosphorylated and S17D mutant which mimics phosphorylation (Bornancin & 
Parker, 1997), does not have any effect on the interaction. Furthermore, the S17A mutant 
when accompanied with CDK5 overexpression still has a decreased association with 
GluN2B. These results suggest that either phosphorylation of GluN2BTail or 
phosphorylation of a different site on spinophilin by CDK5 may be responsible for 
decreased interaction between spinophilin and GluN2BTail. Moreover, we cannot rule out 
that CDK5 binding to either spinophilin or the GluN2BTail may modulate their association 
by changing the conformation of either spinophilin or GluN2B. 
 Spinophilin, Through its PP1-Targeting Role, Attenuates Abundance of PP1 on 
GluN2Btail 
 PP1 interacts directly with spinophilin (Allen et al., 1997; Colbran et al., 1997). 
Our results also showed that PP1 also interacts with GluN2BTail (Figure 13). As a 
consequence spinophilin-GluN2BTail interaction could potentially alter the abundance of 
PP1 on each of these proteins. Therefore, we determined the association of PP1 with 
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GluN2BTail in the presence and absence of spinophilin. Results show that overexpression 
of spinophilin attenuated PP1 bound to GluN2BTail.  
 Since spinophilin has a PP1 targeting role (Allen et al., 1997; Ragusa et al., 2010) 
it should increase the PP1 bound to GluN2BTail unless the domains of spinophilin which 
bind to GluN2BTail and PP1 are overlapping. In order to test this idea, we used a PP1-
binding deficient mutant of spinophilin (F451A) (Hsieh-Wilson et al., 1999). The mutation 
had little to no effect of spinophilin binding to GluN2BTail and if anything actually 
increased the association between these proteins (Figure 15). However, in contrast to WT 
spinophilin, mutant spinophilin had no effect on the association between PP1 and 
GluN2BTail. We predict that only a small portion of spinophilin and GluN2BTail are 
associated with each other in HEK cells. The low intensity of the Co-IP signal that is 
detected in these studies supports this prediction. Therefore, when spinophilin is 
overexpressed, it may displace PP1 from the tail of GluN2B. While a small amount of 
spinophilin-targeted PP1 may still associate with GluN2B, unbound spinophilin sequesters 
a majority of the PP1 away from GluN2B. Previous studies have found that spinophilin 
binding to PP1 can attenuate PP1 activity towards certain substrates (Mathieu Bollen et al., 
2010; Ragusa et al., 2010). Our data demonstrate a different mechanism by which 
spinophilin may compete away PP1 from other interacting proteins.  
 Novel Mechanisms Regulating the Spinophilin/PP1 Interaction 
 Given that spinophilin may sequester PP1 from GluN2B, we next wanted to 
determine mechanisms that modulate the association between PP1 and spinophilin. 
Interestingly, we found that CDK5 activity enhances the association between spinophilin 
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and PP1. PP1 binds to a central domain on spinophilin, containing residues 447-451 
(Ragusa reference, Hsieh Wilson references). PP1α is also known to be phosphorylated by 
CDK5 at Thr320 (Hou et al., 2013). Therefore future studies will need to determine if 
phosphorylation at this site plays a role. Moreover, multiple isoforms of PP1 are known to 
associate with spinophilin, with both the γ1 and α isoforms being predominant interactors. 
However, PP1γ1 does not contain the same Thr320 site. Previous studies have identified 
additional spinophilin binding sites that can enhance spinophilin association with PP1γ1(L. 
C. Carmody, A. J. Baucum, 2nd, M. A. Bass, & R. J. Colbran, 2008). Moreover, while 
F451A mutation of spinophilin completely abrogates binding to the endogenous PP1 
isoform in HEK293 cells (presumably α), it only partially attenuates the association with 
overexpressed PP1γ1. The effect of CDK5 on regulating spinophilin binding with different 
isoforms of PP1 is not known and future studies will determine isoform-specific 
differences between the CDK5-dependent changes in the interaction of spinophilin and 
PP1. 
 Functional Implications of the Spinophilin/NMDAR Interaction 
 To determine the functional consequences of modulating the spinophilin/GluN2B 
interaction and/or spinophilin expression, we utilized MS/MS-based approaches to identify 
and ratiometrically quantify various phosphorylation sites on GluN2BTail in the absence or 
presence of overexpressed spinophilin and PP1. Interestingly, our MS/MS results show a 
significant decrease in Ser1284 phosphorylation caused by overexpression of PP1. This 
decrease was rescued when spinophilin was also overexpressed. Preliminary data 
immunoblotting with a phospho-specific antibody also suggests that Ser1284 
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phosphorylation is attenuated in presence of PP1 and is recovered by overexpression of 
spinophilin.   
 Ser1284 is a CDK5 phosphorylation site. Previous studies show that CDK5 is 
involved in synaptic plasticity, memory and learning (Cheung & Ip, 2007; Hawasli et al., 
2007; Plattner et al., 2014).  Moreover, it is notable that CDK5 phosphorylation of 
NMDARs, especially GluN2B-containing NMDARs, is critical in normal learning and 
memory and synaptic plasticity either through direct phosphorylation of NMDARs (B. S. 
Li et al., 2001; Plattner et al., 2014) or modulation of its partners (Morabito, Sheng, & Tsai, 
2004; Zhang et al., 2008). Consequently, it is intriguing to explore alterations of CDK5 
phosphorylation sites and the molecules responsible for this alteration. Ser1284 (W. Lu et 
al., 2015) and Ser1116 (Plattner et al., 2014) are two CDK5 phosphorylation sites on 
GluN2B. Ser1284 is known to have decreased phosphorylation in ischemic conditions 
while showing no change during LTP simulation or fear condition (W. Lu et al., 2015). All 
in all these data suggest that Ser1284 is a CDK5 phosphorylation site that can be modulated 
by spinophilin-dependent redistribution of PP1.  
 Summary 
Data presented here suggest that the interaction between spinophilin and NMDARs 
is attenuated by CDK5 overexpression and enhanced by PKA overexpression and activity. 
Our preliminary data showed an interaction between spinophilin and GluN1 as well as 
spinophilin and GluN2B in mouse brain. We validated that spinophilin and NMDAR 
interact in heterologous cell lines. We also established that spinophilin interacts with amino 
acids 839-1088 on the C-terminal tail region of GluN2B. We also found that point 
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mutations that mimic phosphorylation of spinophilin at CDK5 site do not change the 
association of GluN2BTail and spinophilin. However co-expression of CDK5 along with 
these point mutant species still attenuates the interaction, suggesting another 
phosphorylation site on either of GluN2B or spinophilin is responsible for the observed 
change in the association. Taken together, these data suggest the modulatory effect of two 
PKs in spinophilin-NMDAR association.  
Functionally, we determined that PP1 overexpression decreases Ser1284 
phosphorylation on GluN2B (Figure 18A). Interestingly, spinophilin can compete off PP1 
from GluN2B and this competition attenuates the PP1-induced decreases in GluN2B 
phosphorylation at Ser1284 of GluN2B (Figure 18B). Consequently, overexpression of 
F451A mutant spinophilin does not have significant effect on modulating PP1 level in 
GluN2B IP (18C).  
 Conclusion and Future Directions 
Parkinson disease is one of the most common neurodegenerative diseases and is 
characterized by the loss of nigrostriatal dopaminergic projections to MSNs in striatum. 
Dopamine depletion has various consequences on MSNs, such as PKA disinhibition of D2 
receptor containing population of neurons and rearrangement of the PSD family members 
on MSN spines. As suggested by an animal model of PD, spinophilin and NMDA receptors 
are two members of PSD that have altered interaction as a result of PD. Possibly, 
spinophilin may play a role in proper localization of NMDARs as well as regulating their 
phosphorylation status. As a result, alterations of the association of spinophilin and 
NMDAR may lead to perturbations in normal synaptic function. 
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Our data suggest GluN1 and GluN2B subunits of NMDARs interact with 
spinophilin. In our future studies we will investigate the possible interaction of GluN2A 
subunit with spinophilin using brain IPs and a heterologous cell system. Moreover, 
immunofluorescence imaging studies using confocal microscopy could help elucidate 
further questions about the co-localization of the various proteins discussed herein. 
While we identified one site on GluN2B that is modulated by spinophilin expression 
in a heterologous cell system, the roles of spinophilin on in vivo NMDAR phosphorylation 
are less clear. Moreover, implications of regulating the spinophilin/PP1 interaction on 
regulating substrate phosphorylation and PP1 targeting to the NMDAR and other synaptic 
proteins are not known. Therefore, future studies will utilize WT and spinophilin KO mice 
to evaluate PP1 binding to, and the phosphorylation of, GluN2B. Moreover, we aim to 
investigate the role of modulating GluN2B phosphorylation at Ser1284 on NMDAR 
localization and function. Additionally, we have reported that Ser1284 phosphorylation of 
GluN2B subunit is increased in the presence of spinophilin. Since Ser1284 phosphorylation 
is strikingly decreased in ischemic conditions, we will also look at spinophilin’s role in 
rescuing the dephosphorylation of NMDAR in oxygen deprived conditions.  
We have also shown that PKAc and CDK5 regulate the association between 
spinophilin and NMDARs. However, the exact phosphorylation sites that modulate the 
association are unclear. To further test this, we plan to generate phospho-mimic mutations 
of GluN1, GluN2B and spinophilin on specific PKA or CDK5 sites and try to uncover the 
exact phosphorylation sites that regulate the association. Furthermore, we intend to 
investigate the effect of other protein kinases such as CaMKII, PKC, Tyrosine kinases and 
Casein kinases on the interaction.  
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Here we also showed that NMDAR/spinophilin interaction is altered in an animal 
model of PD. Further studies utilizing animal models of PD could be useful in assessing 
increases and/or decreases in either kinase or phosphatase levels and/or activity that occur 
concurrently with these altered interactions. Additionally, understanding the pathological 
consequences of these altered interactions on the symptoms of the disease will be critical.   
All in all, the data presented here reveal changes in the interaction between two 
important neuronal proteins. Furthermore, it seems that phosphorylation via PKA and 
CDK5 have a significant effect on spinophilin’s ability to interact with the NMDAR. Our 
exciting data give a novel insight into mechanisms that regulate the interaction between 
these critical synaptic proteins; however, the potential consequences of these changes has 
yet to be fully explored.  
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Figure 1: Spinophilin and GluN1 interact in HEK293 cells.  
HEK293 cells were transfected with HA-spinophilin and/or V5-GluN1. 
Immunoprecipitations and immunoblots were performed with antibodies raised against 
either the HA or the V5 tag. Western blot results show an association between these two 
proteins. Image is representative of 3 independent experiments. 
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Figure 2: Spinophilin associates with GluN2B in mouse brain.  
Immunoprecipitations performed using mouse cortical tissue homogenized in RIPA lysis 
buffer. Immunoprecipitates were blotted using antibodies raised against spinophilin or 
GluN2B. A) Immunoprecipitations and immunoblots were performed with antibodies 
raised against either the spinophilin or GluN2B. B) No GluN2B is co-immunoprecipitated 
with spinophilin in spinophilin KO mouse.  
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Figure 3: Spinophilin associates with the C-terminal domain of GluN2B.  
HEK293 cells were transfected with spinophilin and/or GluN2BTail (HA and V5 tags 
respectively). Immunoprecipitations were performed with antibodies raised against either 
the HA or the V5 tag. Western blots were performed using antibodies raised against either 
GluN2BTail or spinophilin. Western blot results show an association between these two 
proteins. Image is representative of 3 independent experiments. 
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Figure 5: Overexpression of the catalytic subunit of PKA increases spinophilin-GluN1 
association.  
HEK293 cells were transfected with HA-spinophilin and/or V5-GluN1 with and without 
Myc tagged PKAc. A) Immunoprecipitations and immunoblots were performed with 
antibodies raised against either the HA or the V5 tag. B) There was a trend for an increase 
in the amount of GluN1 in the HA IPs in the presence of PKA. p = 0.07. C) There was an 
increase in the amount of spinophilin in V5 IPs in the presence of PKA. *p < 0.05. N=9. 
Graphs show the mean + the standard error of the mean. 
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Figure 6: Overexpression of catalytic subunit of PKA increases spinophilin- GluN2BTail 
association.  
HEK293 cells were transfected with HA-spinophilin and/or V5- GluN2BTail with and 
without Myc tagged PKA. A) Immunoprecipitations and immunoblots were performed 
with antibodies raised against either the HA or the V5 tag. B) There was a trend for an 
increase in the amount of GluN2B in Spinophilin (HA) IPs when PKA was overexpressed. 
**p < 0.01. C) There was a significant increase in the amount of spinophilin in GluN2B 
(V5) IPs when PKA was overexpressed. ***p < 0.001. N=10. Graphs show the mean + the 
standard error of the mean. 
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Figure 7: Activation of endogenous PKA increases spinophilin-GluN1 association. 
 HEK293 cells were transfected with HA-spinophilin and/or V5-GluN1. Endogenous PKA 
was activated through the use of forskolin and IBMX. A) Immunoprecipitations and 
immunoblots were performed with antibodies raised against either the HA or the V5 tag. 
B) There was a significant increase in the amount of GluN1 in Spinophilin (HA) IPs 
following activation with PKA. *p < 0.05 N=8. Graph shows the mean + the standard error 
of the mean.  
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Figure 8: Activation of endogenous PKA increases spinophilin- GluN2BTail association.  
HEK293 cells were transfected with HA-spinophilin and/or V5- GluN2BTail. Endogenous 
PKA was activated through the use of forskolin and IBMX. A) Immunoprecipitations and 
immunoblots were performed with antibodies raised against either the HA or the V5 tag. 
B) There was a significant increase in the amount of GluN2BTail in Spinophilin (HA) IPs 
following activation of PKA. **p < 0.01. C) There was a significant increase in the amount 
of Spinophilin in the GluN2BTail (V5) IPs following activation of PKA. **p < 0.01. N=6. 
Graphs show the mean + the standard error of the mean. 
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Figure 9: Long-term activation of endogenous PKA increases spinophilin-GluN1-GluN2B 
association. 
 HEK293 cells were transfected with spinophilin and/or GluN1-GluN2B. Endogenous 
PKA was activated through the use of forskolin and IBMX. Immunoprecipitations were 
performed with antibodies raised against either the HA or the V5 or Myc tag. Western blots 
were performed using antibodies raised against either Spinophilin or GluN1 or GluN2B. 
Preliminary data suggest an increase in the association of NMDAR and spinophilin in 
presence of activated PKA. Data are representative of 3 independent experiments.         
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Figure 10: Spinophilin/GluN2BTail association is decreased upon CDK5/p35 
overexpression in HEK293 cells.  
HEK293 cells were transfected with HA-spinophilin and/or V5- GluN2BTail. A) 
Immunoprecipitations and immunoblots were performed with antibodies raised against 
either HA or the V5 epitpoe tags. B) There was a significant decrease in the amount of 
GluN2BTail in Spinophilin (HA) IPs when CDK5 was overexpresssed. ****p < 0.0001. 
N=8. Graphs show the mean + the standard error of the mean. 
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Figure 11: Phosphorylation of Ser17 on spinophilin is not responsible for the decrease in 
spinophilin-GluN2BTail interaction.   
HEK293 cells were transfected with WT, S17A, or S17D HA-spinophilin and/or V5 
GluN2BTail. A) Immunoprecipitations and immunoblots were performed with antibodies 
raised against either the HA or the V5 tag. B) Quantified data show that S17A/D mutation 
does not have effect on Spinophilin- GluN2BTail association while CDK5 presence still 
decreases the association.  *p < 0.05, ***p < 0.001.  N=6. Graphs show the mean + the 
standard error of the mean. 
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Figure 12: Overexpression of CDK5 increases spinophilin-PP1 association. 
HEK293 cells were transfected with HA-tagged spinophilin with or without CDK5-p35 
overexpression. Spinophilin IPs were performed using antibodies raised against HA tag. 
A) Immunoblots were performed using antibodies against HA tag and endogenous PP1. B) 
These data show a significant increase in the amount of PP1 in Spinophilin (HA) IPs when 
CDK5 was overexpresssed.*p < 0.05. N=6. Graphs show the mean + the standard error of 
the mean. 
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Figure 13: Spinophilin decreases the amount of PP1γ1 bound to the C-terminal domain of 
the GluN2B.  
HEK293 cells were transfected with PP1γ1 and/or GluN2BTail (Myc and V5 tags 
respectively) with and without HA tagged spinophilin overexpression. 
Immunoprecipitations were performed with antibodies raised against either the Myc or the 
V5 tag. A) Immunoblots were performed using antibodies raised against either the 
GluN2BTail or PP1. B and C) There was a decrease in the amount of PP1 and GluN2BTail 
in GluN2BTail (V5) and PP1 IPs respectively when spinophilin is overexpressed. *p < 0.05 
N=7. Graphs show the mean + the standard error of the mean. 
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Figure 14: F451A mutation on spinophilin attenuates its ability to bind to PP1. 
HEK293 cells were transfected with F451A mutant (Mu) spinophilin and/or WT 
spinophilin in the absence or presence of Myc-tagged PP1. Immunoprecipitations were 
performed with antibodies raised against either the HA tag. Immunoprecipitates were 
immunoblotted for endogenous PP1 (A) or overexpressed PP1γ1 (B). Graphs show the 
mean + the standard error of the mean. 
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Figure 15: WT, but not F451A mutant spinophilin alters the PP1 association with the C-
terminal domain of GluN2B.  
HEK293 cells were transfected with PP1γ1 and/or GluN2BTail (Myc and V5 tags 
respectively) with and without HA tagged wildtype or mutant (F451A) spinophilin. 
Immunoprecipitations were performed with antibodies raised against either the Myc or the 
V5 tag. Western blots were performed using antibodies raised against either V5 tag, HA 
tag, or PP1γ1. B) Quantified data show an overall significant ANOVA p-value (p < 0.05). 
A Tukey post hoc test revealed a significant decrease of PP1 association with GluN2BTail 
(**p < 0.01) when WT spinophilin is present. However, there was no significant difference 
(p > 0.05) in the interaction between PP1 and GluN2BTail in presence or absence of F451A 
spinophilin. N=8. Graphs show the mean + the standard error of the mean. 
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Figure 16: PKA phosphorylates multiple serine residues on GluN2B.  
HEK293 cells were transfected as indicated. Immunoprecipitations were performed with 
antibodies for the V5 tag (GluN2BTail) and samples were separated by SDS-PAGE then 
stained with Imperial stain. Phosphorylation at Ser929/930 (A), Ser940 (B), Ser1050 (C), 
and Ser1303 (D) was ratiometrically quantified as described in methods in the absence (-) 
or presence (+) of PKA. N=3. Graphs show the mean + the standard error of the mean. 
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Figure 17: Spinophilin rescues PP1-induced dephosphorylation of S1284 on GluN2B. 
 HEK293 cells were transfected as indicated. Immunoprecipitations were performed with 
antibodies for the V5 tag (GluN2BTail) and samples were separated by SDS-PAGE then 
stained with Imperial stain. A) A one-way ANOVA revealed a significant treatment effect 
(p < 0.0001). A Tukey post-hoc test revealed a significant decrease in S1284 
phosphorylation when PP1 was added ****p < 0.0001. This decrease was attenuated by 
overexpression of spinophilin ****p<0.0001. N = 3. B) Western blot showing the increase 
in phosphorylation of S1284 when spinophilin is overexpressed compared to decrease in 
the phosphorylation caused by PP1 alone. Immunoprecipitations were conducted using 
antibodies for the V5 (GluNBTail) tag. Western blots were obtained using antibodies for 
phospho-S1284 and total V5 tag. C) Preliminary data suggest that PP1 decreases the S1284 
phosphorylation signal and that this decrease is rescued by overexpression of spinophilin. 
N = 2. Graphs show the mean + the standard error of the mean 
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Figure 18: PP1 binding to GluN2B is modulated by spinophilin. 
A) PP1 binds to GluN2Btail and dephosphorylates GluN2B at Ser1284. WT (B), but not 
F451A (C) spinophilin displaces PP1 from GluN2Btail and rescues PP1 dephosphorylation 
at GluN2B at Ser1284
A 
B 
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